Rostrum Medical Welcomes Ms. Golddy Kaur to Rostrum’s Board of Directors

September 7, 2022 - Vancouver, B.C.

Rostrum is pleased to announce the appointment of Ms. Golddy Kaur to Rostrum Medical’s board of directors. She joins Scott Philipps, Daguang Wang, Dr Georg Brady and Awni Ayoubi to expand the company’s strategic capabilities and solidify our path to commercialization of The VQm® System.

 Ms. Kaur is an experienced global medical device executive. She served as SVP Product Leader for Profound Medical where she led global operational functions in the areas of Quality, Regulatory, Clinical Trials, R&D, Engineering, and Operations, with full financial accountability. She was also the Director of Regulatory & Quality of Natus Medical, a global leader in EEG, EMG, and IOM technologies and served Philips Medical and C. R. Bard in the areas of Quality and Regulatory. Her experience in business management, strategy development, commercialization, QA/RA & clinical research will complement and add to the board’s capabilities.

"On behalf of the entire Board of Directors, it is a pleasure to welcome Ms. Kaur to our team," said Awni Ayoubi, President and Chief Executive Officer of Rostrum Medical. “Rostrum’s success during past and current challenges is compliment to Rostrum’s dedicated team, the clinical guidance of our world renown medical advisory board and the advice of experienced board directors.”

About Rostrum Medical

Rostrum Medical is dedicated to empowering medical practitioners with new and useful solutions to help solve everyday challenges that medical professionals face. Rostrum was established with a goal to deliver novel solutions to problematic uncertainties in modern day practice. With a team of some of the world’s most progressive clinicians, combined with engineering and business expertise with a history of commercial success, Rostrum is driven by one mission – to address clinical needs in healthcare.

About VQm Pulmonary Health Monitor™

The VQm Pulmonary Health Monitor™ is a novel monitoring device that aims to provide clinicians with near real-time physiological insight into the effects of changes in lung mechanics of Mechanically Ventilated patients. The VQm PHM™ is developed with the intention to assist physicians in their management of mechanical ventilation by providing measurements of the following physiological parameters: Shunt Index (Qsi), Dead space, Pulmonary Blood Flow (PBF), and Functional Residual Capacity (FRC).

For more information or inquiries, please email: media@rostrummedical.com